Cytokines induced during chronic hepatitis B virus infection promote a pathway for NK cell-mediated liver damage.
Cytokines induced during chronic hepatitis B virus infection promote a pathway for NK cell-mediated liver damage.
复制标题
DOI:
10.1084/jem.20061287
复制
发表时间:
2007-03-19
期刊:
影响因子:
--
通讯作者:
Maini MK
中科院分区:
文献类型:
--
作者:
Dunn C;Brunetto M;Reynolds G;Christophides T;Kennedy PT;Lampertico P;Das A;Lopes AR;Borrow P;Williams K;Humphreys E;Afford S;Adams DH;Bertoletti A;Maini MK
Hepatitis B virus (HBV) causes chronic infection in more than 350 million people worldwide. It replicates in hepatocytes but is non-cytopathic; liver damage is thought to be immune mediated. Here, we investigated the role of innate immune responses in mediating liver damage in patients with chronic HBV infection. Longitudinal analysis revealed a temporal correlation between flares of liver inflammation and fluctuations in interleukin (IL)-8, interferon (IFN)-α, and natural killer (NK) cell expression of tumor necrosis factor–related apoptosis-inducing ligand (TRAIL) directly ex vivo. A cross-sectional study confirmed these findings in patients with HBV-related liver inflammation compared with healthy carriers. Activated, TRAIL-expressing NK cells were further enriched in the liver of patients with chronic HBV infection, while their hepatocytes expressed increased levels of a TRAIL death–inducing receptor. IFN-α concentrations found in patients were capable of activating NK cells to induce TRAIL-mediated hepatocyte apoptosis in vitro. The pathogenic potential of this pathway could be further enhanced by the ability of the IFN-α/IL-8 combination to dysregulate the balance of death-inducing and regulatory TRAIL receptors expressed on hepatocytes. We conclude that NK cells may contribute to liver inflammation by TRAIL-mediated death of hepatocytes and demonstrate that this non-antigen–specific mechanism can be switched on by cytokines produced during active HBV infection.
登录
查看更多内容
DOI:
10.1084/jem.189.2.441
发表时间:
1999-01-18
期刊:
The Journal of experimental medicine
影响因子:
--
作者:
Afford SC;Randhawa S;Eliopoulos AG;Hubscher SG;Young LS;Adams DH
通讯作者:
Adams DH
影响因子:
4.4
作者:
Campbell, JJ;Qin, SX;Butcher, EC
通讯作者:
Butcher, EC
影响因子:
25.7
作者:
Brunetto, MR;Oliveri, F;Bonino, F
通讯作者:
Bonino, F
DOI:
10.1084/jem.186.7.1077
发表时间:
1997-10-06
期刊:
The Journal of experimental medicine
影响因子:
--
作者:
Khabar KS;Al-Zoghaibi F;Al-Ahdal MN;Murayama T;Dhalla M;Mukaida N;Taha M;Al-Sedairy ST;Siddiqui Y;Kessie G;Matsushima K
通讯作者:
Matsushima K
影响因子:
4.4
作者:
Kafrouni, MI;Brown, GR;Thiele, DL
通讯作者:
Thiele, DL